Literature DB >> 3743926

Glicentin 1-61 probably represents a major fraction of glucagon-related peptides in plasma of anaesthetized uraemic pigs.

F G Baldissera, J J Holst.   

Abstract

Uraemia was induced in pigs by ligation of the renal vascular pedicle, and uraemic plasma was analysed for glucagon and glucagon-related peptides. A preponderance of large molecular weight (Mr) components comprising glicentin and moieties of slightly lower Mr was found, accounting for 73 +/- 3% (mean +/- SEM, n = 12) of the total plasma glucagon-like immunoreactivity. Comparisons with glicentin 1-61, produced by controlled, stepwise, consecutive digestion of purified natural glicentin with carboxypeptidases (carboxypeptidase A followed by carboxypeptidase B, and again by carboxypeptidase A and B), gel filtration, ion exchange chromatography, reverse phase HPLC and radioimmunoassays for the glucagon sequences 6-15 and 19-29 and for the glicentin sequence 12-30 all indicate that glicentin 1-61 constitutes approximately 57% of the large Mr glucagon-related peptides found in uraemia in pigs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3743926     DOI: 10.1007/bf00506540

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  21 in total

1.  Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Metabolism       Date:  1975-10       Impact factor: 8.694

2.  Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay.

Authors:  F Stadil; J F Rehfeld
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

3.  Large glucagon immunoreactivity in extracts of pancreas.

Authors:  D Rigopoulou; I Valverde; J Marco; G Faloona; R H Unger
Journal:  J Biol Chem       Date:  1970-02-10       Impact factor: 5.157

4.  Glicentin is present in the pig pancreas.

Authors:  S P Sheikh; F G Baldissera; F O Karlsen; J J Holst
Journal:  FEBS Lett       Date:  1985-01-01       Impact factor: 4.124

5.  Purification and chemical characterization of a glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreas.

Authors:  L Thim; A J Moody
Journal:  Biochim Biophys Acta       Date:  1982-05-03

6.  Pathogenesis and characterization of hyperglucagonemia in the uremic rat.

Authors:  D S Emmanouel; J B Jaspan; S F Kuku; A H Rubenstein; A I Katz; A H Huen
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

7.  Somatostatin 1-28 circulates in human plasma.

Authors:  F G Baldissera; M A Munoz-Perez; J J Holst
Journal:  Regul Pept       Date:  1983-04

8.  Hamster preproglucagon contains the sequence of glucagon and two related peptides.

Authors:  G I Bell; R F Santerre; G T Mullenbach
Journal:  Nature       Date:  1983-04-21       Impact factor: 49.962

9.  Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours.

Authors:  J J Holst
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

10.  Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity.

Authors:  J J Holst
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

View more
  7 in total

Review 1.  Proglucagon-derived peptides: nomenclature, biosynthetic relationships and physiological roles.

Authors:  J M Conlon
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

2.  Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

Authors:  Nicolai J Wewer Albrechtsen; Bolette Hartmann; Simon Veedfald; Johanne A Windeløv; Astrid Plamboeck; Kirstine N Bojsen-Møller; Thomas Idorn; Bo Feldt-Rasmussen; Filip K Knop; Tina Vilsbøll; Sten Madsbad; Carolyn F Deacon; Jens J Holst
Journal:  Diabetologia       Date:  2014-06-03       Impact factor: 10.122

3.  Postprandial insulin secretion after gastric bypass surgery: the role of glucagon-like peptide 1.

Authors:  Jens Juul Holst
Journal:  Diabetes       Date:  2011-09       Impact factor: 9.461

4.  Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme-linked immunosorbent assay.

Authors:  Toshihiro Matsuo; Jun-Ichiro Miyagawa; Yoshiki Kusunoki; Masayuki Miuchi; Takashi Ikawa; Takafumi Akagami; Masaru Tokuda; Tomoyuki Katsuno; Akira Kushida; Takashi Inagaki; Mitsuyoshi Namba
Journal:  J Diabetes Investig       Date:  2015-08-24       Impact factor: 4.232

5.  Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production.

Authors:  Nicolai J Wewer Albrechtsen; Rune E Kuhre; Daniel Hornburg; Christian Z Jensen; Mads Hornum; Carsten Dirksen; Maria Svane; Lærke S Gasbjerg; Nils B Jørgensen; Maria N Gabe; Emilie Balk-Møller; Reidar Albrechtsen; Marie Winther-Sørensen; Katrine D Galsgaard; Felix Meissner; Tina Jorsal; Asger Lund; Tina Vilsbøll; Rasmus Eliasen; Kirstine N Bojsen-Møller; Thomas Idorn; Carolyn F Deacon; Filip K Knop; Mette M Rosenkilde; Bolette Hartmann; Bo Feldt-Rasmussen; Matthias Mann; Sten Madsbad; Jens J Holst
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

6.  Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery.

Authors:  Geoffrey P Roberts; Richard G Kay; James Howard; Richard H Hardwick; Frank Reimann; Fiona M Gribble
Journal:  Surg Obes Relat Dis       Date:  2018-02-03       Impact factor: 4.734

7.  Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study.

Authors:  Kleopatra Alexiadou; Joyceline Cuenco; James Howard; Nicolai Jacob Wewer Albrechtsen; Ibiyemi Ilesanmi; Anna Kamocka; George Tharakan; Preeshila Behary; Paul R Bech; Ahmed R Ahmed; Sanjay Purkayastha; Robert Wheller; Matthieu Fleuret; Jens Juul Holst; Stephen R Bloom; Bernard Khoo; Tricia M-M Tan
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.